[1]. Kimura N, Shiga K, Kaneko K, Sugisawa C, Katabami T, Naruse M. The Diagnostic Dilemma of GATA3 Immunohistochemistry in Pheochromocytoma and Paraganglioma. Endocr Pathol. 2020 Jun;31(2):95-100.

[2]. Dermawan JK, Mukhopadhyay S, Shah AA. Frequency and extent of cytokeratin expression in paraganglioma: an immunohistochemical study of 60 cases from 5 anatomic sites and review of the literature. Hum Pathol. 2019 Nov; 93:16-22.

[3]. Boedeker CC, Ridder GJ, Schipper J. Paragangliomas of the head and neck: diagnosis and treatment. Fam Cancer. 2005;4(1):55-9.

[4]. Stoeckli SJ, Schuknecht B, Alkadhi H et al. Evaluation of paragangliomas presenting as a cervical mass on color-coded doppler sonography. Laryngoscope 2002; 112: 143–6.

[5]. Mete O, Asa SL, Gill AJ, Kimura N, de Krijger RR, Tischler A. Overview of the 2022 WHO Classification of Paragangliomas and Pheochromocytomas. Endocr Pathol. 2022 Mar;33(1):90-114.